Dr. Craig Clifford is Director of Clinical Studies for Hope Veterinary Specialists. He is a graduate of Mississippi State University College of Veterinary Medicine, and he earned an MS in Animal Science/Virology from the University of Delaware. After completing an internship and a medical oncology residency at the University of Pennsylvania, he became a diplomate of the American College of Veterinary Internal Medicine (Oncology) in 2003. He joined Red Bank Veterinary Hospital in 2002 as a medical oncologist. Dr. Clifford was responsible for the creation of a clinical studies program at Red Bank Veterinary Hospital. He has authored/co-authored over 50 papers and book chapters relevant to his field. He was responsible for the creation of Veterinary Cancer Society‘s resident review session and the Northeast Veterinary Co-operative Oncology Group. Dr. Clifford has served on the VCS executive board, ACVIM Exam Rating Committee, Residency Training and Credentials Committee, Oncology Pathology Working Group, Co-chair of the Standards of Excellence in Residency Education Task Force and Examiner for the Australian Scientist’s Oncology Specialty Exam. He also serves on the Scientific Advisory Boards for several charities.
Dr. Susan Ettinger
Dr. Susan Ettinger is a staff medical oncologist with Animal Specialty Center. She is co-author of The Dog Cancer Survival Guide www.dogcancerbook.com. She graduated Tufts University with a Bachelor of Science degree in biology, then graduated Cornell College of Veterinary Medicine in 1998. Dr. Ettinger completed an internship in small animal medicine and surgery, followed by a residency in medical oncology at The Animal Medical Center in NYC. She received the Connie E. Leifer Memorial Award for her research project and presentation on vaccine-associated sarcomas in cats. Dr. Ettinger served as a staff oncologist at South Bay Veterinary Associates in San Jose, CA, and was affiliated with the Veterinary Tumor Institute in Santa Cruz. Most recently, Dr. Ettinger was the staff oncologist at Long Island Veterinary Specialists in New York. Prior to her residency, Dr. Ettinger was a radiation oncology research associate at Duke University Medical Center, and an investigator in a five-year oncology study with patients at North Carolina State University College of Veterinary Medicine. Additionally, Dr. Ettinger has served as an instructor in the Department of Molecular Medicine and as an oncology associate with the Comparative Cancer Program at Cornell University. Dr. Ettinger is board certified by the American College of Veterinary Internal Medicine (Oncology).
Dr Kai-Biu Shiu BVMS, MRCVS, DACVIM (Oncology) is a clinical oncologist and specialty director at Veterinary Emergency Service / Veterinary Specialty Center (www.vesvsc.com) in Middleton, Wisconsin. He is the chair of the national Puppy Up Scientific Advisory Board, and is the co-chair of the Puppy Up Madison walks that have raised over $200,000 over the past two years. He has a bachelors degree in Veterinary Pathology from the Royal Veterinary College, London, and his veterinary degree was obtained at the University of Glasgow, Scotland in 2006. After veterinary school, Dr Shiu completed a rotating small animal medicine and surgery internship at Cornell University, Ithaca NY. He then moved to Madison to pursue a three year residency in Medical Oncology at UW Madison and became board certified with the ACVIM in 2010. He served as president of Dane County Veterinary Medical Association from 2013-2015 and serves on the Wisconsin Veterinary Medical Association Professional Education Committee. He is a member of the Veterinary Cancer Society, DCVMA, AVMA, WVMA, RCVS and ACVIM. Dr. Shiu has performed basic and clinical research in both human, canine and feline oncology but his primary focus is compassionate individualized care for his patients that have cancer. He lives with his wife and his bowtie wearing cat, Baxter.
Dr. Nicole Ehrhart graduated from the University of Pennsylvania College of Veterinary Medicine in 1990. She completed an internship in general medicine and surgery at the Animal Medical Center in New York City. She completed her surgical residency and Masters degree in Clinical Sciences at Colorado State in 1994, and she became Board Certified in Surgery in 1995 during the first year of a 2 year postdoctoral Fellowship in Surgical Oncology and Orthopedic Research. Following completion of her Fellowship, she was recruited in 1996 to the University of Illinois College of Biomedical Sciences as an Assistant Professor in Surgical Oncology. In 2002, concurrent with the opening of the new Flint Animal Cancer Center at Colorado State University College of Veterinary Medicine and Biomedical Sciences, she returned to Colorado as a Professor of Surgical Oncology. She holds joint faculty appointments in the School of Biomedical Engineering and the Cell and Molecular Biology Programs, is a member of the Gates Regenerative Medicine Center at the University of Colorado, and is a University of Colorado Cancer Center member.
Dr. David Ruslander’s primary specialty is radiation oncology, but he is board certified in medical oncology as well. Prior to joining VSH in 2004, Dr. Ruslander worked primarily in an academic environment, with many publications to his credit. He graduated with a veterinary degree from Cornell in 1988 and started his career as an intern at the Western College of Veterinary Medicine in Saskatoon, Canada. Dr. Ruslander completed a medical oncology residency at the Tufts University School of Veterinary Medicine. He came to NCSU in North Carolina in 1992 as a Visiting Assistant Professor in the medical oncology department. A desire for continued learning took him to the University of Zurich in Switzerland, where he worked as an oncologist and received training in radiation oncology. Dr. Ruslander was on the faculty at Tufts from 1997 to 2000 and then at NCSU from 2000-2004 before joining VSH. Dr. Ruslander is a past president of the Veterinary Cancer Society.
Dr. Henry is a Professor with dual appointments at the College of Veterinary Medicine and the School of Medicine at the University of Missouri. After earning her DVM from Auburn University in 1990, she practiced small animal medicine in Alabama and Georgia, developing a passion for care of veterinary cancer patients. She returned to Auburn for an Oncology Residency and concurrent MS degree program. Board certified since 1994, Dr. Henry served on the Washington State University faculty (1993 to 1997) before relocating to the University of Missouri. She has served on the American College of Veterinary Internal Medicine (ACVIM) Board of Regents and is past president of both the Veterinary Cancer Society and the ACVIM Specialty of Oncology. Dr. Henry has authorship on over 75 manuscripts, 15 book chapters and an oncology textbook published last year. In April 2010, Henry was named Faculty Facilitator for the Mizzou Advantage One Health/One Medicine initiative by the Office of the Provost-a position that serves to foster multidisciplinary educational and research opportunities between human and veterinary medicine and the basic sciences, both inside and outside of the University of Missouri. Her research interests include canine bladder cancer, mammary cancer, osteosarcoma, and comparative oncology/cancer epidemiology.
Dr. Heather Wilson is an assistant professor of veterinary medicine at Texas A&M University. She earned her D.V.M. of Veterinary Medicine from the University of Tennessee in 2003, and became a subsequent Diplomate Oncology, ACVIM in 2007. Dr. Wilson regularly writes research papers for top publications in her field. Her research is concentrated in two areas: The first focuses on identifying and characterizing tumor-initiating cells in solid tumors with a one health perspective (i.e. tumors’ similarities and treatment implications across species). The second focus involves clinical trials in client-owned dogs with spontaneously developing tumors, which is used as a basis for informing human clinical trials. Much of this research also has a one health implication designed to streamline drugs or therapies for human trials, decreasing the cost of drug approval while improving therapeutic options for dogs afflicted with cancer.
Dr. Chick Weisse is a staff doctor at the Animal Medical Center of New York City. He earned a Bachelor of Arts (BA) from Boston University in 1992 with a subsequent Veterinary Medical Doctor (VMD) from University of Pennsylvania in 1998. Dr. Weisse is now a board-certified veterinary surgeon and has extensive experience in endovascular and interventional procedures. He is a specialist in Interventional Radiology, which uses imaging to deliver catheters, stents, and the like into tubular structures such as blood vessels, the urinary system, and the respiratory system; these methods were previously used on humans, but Dr. Weisse is developing them for pets. The benefits of his research include decreased morbidity/mortality rates, minimal anesthesia time, reduced hospital stay, and lower costs to pet parents.